当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Junya Kanda
It remains unclear whether the HLA haplotype of unconnected cord blood (UCB) should be matched to that of the case in single UCB transplantation. Therefore, using data from a Japanese registry, we anatomized the effect of haplotype matching on issues. Cases with hematologic conditions aged 16 times or aged who had experienced their first transplant were included (N = 1347). The goods of haplotype matching and high- frequence HLA haplotype on issues were anatomized. Median patient age was 55 times. The accretive frequentness of neutrophil engraftment among groups with 0, 1, and 2 HLA haplotype matches were 79, 82, and 88, independently( P = .008). In a multivariate analysis, the group with 0 haplotype matches was hardly associated with worse neutrophil engraftment (P = .087) and significantly associated with platelet engraftment (P = .044) compared with the group with 1 haplotype match. Twohaplotype matches were associated with a advanced threat of relapse. In the group with 1 haplotype match, the top 3 participated haplotypes were HLA haplotype matching might be considered to ameliorate engraftment. Two- haplotype matches should be avoided if the relapse threat is high. The haplotype itself may have an effect on the threat of acute graft- versus- host complaint and relapse.